Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma



Status:Recruiting
Conditions:Prostate Cancer, Cancer, Bladder Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:2/10/2018
Start Date:November 27, 2017
End Date:December 2018
Contact:Matthew Zibelman, MD
Email:matthew.zibelman@fccc.edu
Phone:215 214 1515

Use our guide to learn which trials are right for you!

Defining the Genomic and Histologic Landscape of Primary and Metastatic Tumors With Divergent Kinetics in Patients With Renal Cell Carcinoma (RCC) and Urothelial Carcinoma (UC) Treated With Immune Checkpoint Blockade (ICB)

This is a comparative study using resected/ biopsied tumors samples collected from renal cell
carcinoma and urothelial carcinoma patients who underwent surgical removal of lesions,
followed by immune checkpoint blockade (ICB) treatment targting programmed cell death 1 (PD1)
but developed new lesions later were also removed and stored in the biosample repository
(BSR). The histology and genomic analysis of the pre-treatment and metastatic samples from
the same patient would be used to find out the changes that may have lead to metastasis.
Also, metastatic samples from ICB naive patients would be collected and compared with those
from ICB treated patients to find out if the metastasis in treated patients was due to
development of reistance.


Inclusion Criteria:

- Eligible patients will include retrospectively identified patients with RCC or UC who
have received treatment with ICB and achieved clinical benefit but subsequently
developed a solitary new/progressive lesion that was removed surgically. Patients with
other tumor types who otherwise meet criteria may be included at a later time

- Additionally, a group of patients with RCC who have undergone a metastasectomy but who
did not receive treatment with ICB will be identified. These patients may be
approached for study participation to serve as a comparator group

Exclusion Criteria:
We found this trial at
1
site
Philadelphia, Pennsylvania 19111
Phone: 215-728-4790
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials